Canaccord Genuity Group initiated coverage on shares of Prestige Consumer Healthcare (NYSE:PBH – Get Rating) in a research report report published on Thursday, Marketbeat.com reports. The firm issued a buy rating and a $71.00 price target on the stock.
A number of other equities analysts have also issued reports on the stock. Oppenheimer reduced their target price on shares of Prestige Consumer Healthcare to $63.00 in a research report on Thursday, September 29th. Canaccord Genuity Group assumed coverage on shares of Prestige Consumer Healthcare in a report on Wednesday. They issued a buy rating and a $71.00 price objective on the stock. StockNews.com assumed coverage on shares of Prestige Consumer Healthcare in a report on Wednesday, October 12th. They issued a buy rating on the stock. Finally, DA Davidson restated a neutral rating on shares of Prestige Consumer Healthcare in a report on Tuesday, August 9th. One investment analyst has rated the stock with a hold rating and five have issued a buy rating to the company. According to data from MarketBeat, the company has a consensus rating of Moderate Buy and an average target price of $68.75.
Prestige Consumer Healthcare Price Performance
Shares of PBH stock opened at $59.75 on Thursday. Prestige Consumer Healthcare has a 1 year low of $48.51 and a 1 year high of $63.47. The firm’s 50 day moving average is $53.02 and its 200-day moving average is $55.19. The firm has a market capitalization of $2.96 billion, a price-to-earnings ratio of 14.50, a PEG ratio of 1.78 and a beta of 0.55. The company has a current ratio of 2.21, a quick ratio of 1.29 and a debt-to-equity ratio of 0.89.
Institutional Investors Weigh In On Prestige Consumer Healthcare
Prestige Consumer Healthcare Company Profile
Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.
- Get a free copy of the StockNews.com research report on Prestige Consumer Healthcare (PBH)
- MarketBeat: Week in Review 11/14 – 11/18
- Target’s Double Bottom Might Have Just Been Confirmed
- How High Can the Fed Go? How to Trade it
- Does ASML’s November Rally Have Staying Power?
- Verra Mobility Stock Has Returned Back to the Station
Receive News & Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.